KRAS-IN-49 (compound 7b) is a selective covalent KRAS G13C inhibitor. It forms a covalent bond with Cys13 of KRAS G13C and is utilized in research pertaining to non-small cell lung cancer (NSCLC).
Target:
Ras
* VAT and and shipping costs not included. Errors and price changes excepted
